Skip to content
Read about how we're working to end cancer for good in HICCC's 2024 Annual Report.
Our researchers are helping to turn the discoveries we make into tomorrow's advanced treatments for our patients.
We work with our communities and patients to remove access barriers to cancer prevention, screening, treatment and survivorship services.
Learn more about the Irving Cancer Drug Discovery Program (ICDDP) at the Herbert Irving Comprehensive Cancer Center.
We're dedicated to developing the next generation of researchers and physicians through cross-disciplinary training and fellowship programs
Melissa Accordino, MD, tackles solutions to long-term side effects, like peripheral neuropathy, that some breast cancer survivors experience after overcoming the disease.
Data from a new retrospective study finds that patients undergoing active chemotherapy were not at an increased risk of getting COVID-19.